Prevalence of attention-deficit hyperactivity disorder in older adults in The Netherlands
Background: Little is known about the prevalence of attention-deficit hyperactivity disorder (ADHD) among older adults. Aims: To estimate the prevalence of the syndromatic and symptomatic DSM-IV ADHD diagnosis in older adults in The Netherlands. Method: Data were used from the Longitudinal Aging Study Amsterdam (LASA). At baseline, 1494 participants were screened with an ADHD questionnaire and in 231 respondents a structured diagnostic interview was administered. The weighted prevalence of ADHD was calculated. Results: The estimated prevalence rate of syndromatic ADHD in older adults was 2.8%;... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2012 |
Reihe/Periodikum: | Michielsen , M , Semeijn , E J , Comijs , H C , van de Ven , P M , Beekman , A T F , Deeg , D J H & Kooij , J J S 2012 , ' Prevalence of attention-deficit hyperactivity disorder in older adults in The Netherlands ' , British Journal of Psychiatry , vol. 201 , no. 4 , pp. 298-305 . https://doi.org/10.1192/bjp.bp.111.101196 |
Schlagwörter: | /dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being / name=SDG 3 - Good Health and Well-being |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26844405 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://research.vu.nl/en/publications/8ba96bda-23a2-4dd6-a686-634ecc215d5a |
Background: Little is known about the prevalence of attention-deficit hyperactivity disorder (ADHD) among older adults. Aims: To estimate the prevalence of the syndromatic and symptomatic DSM-IV ADHD diagnosis in older adults in The Netherlands. Method: Data were used from the Longitudinal Aging Study Amsterdam (LASA). At baseline, 1494 participants were screened with an ADHD questionnaire and in 231 respondents a structured diagnostic interview was administered. The weighted prevalence of ADHD was calculated. Results: The estimated prevalence rate of syndromatic ADHD in older adults was 2.8%; for symptomatic ADHD the rate was 4.2%. Younger elderly adults (60-70 years) reported significantly more ADHD symptoms than older elderly adults (71-94 years). Conclusions: This is the first epidemiological study on ADHD in older persons. With a prevalence of 2.8% the study demonstrates that ADHD does not fade or disappear in adulthood and that it is a topic very much worthy of further study. Declaration of interest A.T.F.B. has received an unrestricted research grant from Eli Lilly and AstraZeneca and has been a speaker for Lundbeck and Eli Lilly. J.J.S.K. is a speaker for Eli Lilly, Janssen and Shire and has received unrestricted research grants for this study from Shire, as well as for another study from Janssen.